Biosimilars: a snapshot of latest developments
Clinical update Previous     Next

Biosimilars: a snapshot of latest developments

Daniel Allen Health writer

Essential facts

Biosimilar medicines are made or derived from biological rather than chemical ingredients. As with standard medicines, when a biologic’s patent expires, it can be reproduced by other companies.

Cancer Nursing Practice. 18, 3, 11-11. doi: 10.7748/cnp.18.3.11.s11

You need a subscription to read the full article